{"id":"W2133329597","doi":"10.1016/s1474-4422(13)70308-9","title":"Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":570,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Toronto","funders":"Serono Symposia International Foundation; Universitätsspital Basel; Universität Basel","keywords":"Teriflunomide; Double blind; Multiple sclerosis; Medicine; Placebo; Internal medicine; Physical therapy; Alternative medicine; Psychiatry; Pathology; Fingolimod","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001536053,0.002112787,0.004224328,0.000512315,0.0007689811,0.0009572292,0.001065036,0.00285219,0.00748347],"category_scores_gemma":[0.001706843,0.0007478676,0.002955009,0.0004994151,0.001187597,0.00142196,0.0004266377,0.003058865,0.001474139],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008142138,"about_ca_system_score_gemma":0.00108736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001678348,"about_ca_topic_score_gemma":0.004349779,"domain_scores_codex":[0.9995296,0.0002106554,0.00003905347,0.00008738377,0.00003509588,0.00009812161],"domain_scores_gemma":[0.9992343,0.0002054361,0.0001748353,0.00006128769,0.00004758751,0.0002765963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.984983,0.001939459,0.000276157,0.0008640844,0.0008811437,0.00005263376,0.00004710332,0.000149156,0.001732011,0.00007263203,0.0007683409,0.008234248],"study_design_scores_gemma":[0.9831331,0.01552572,0.0006066173,0.00002703768,0.0002333197,0.00002017176,0.00001250302,0.00007192288,0.00007561637,0.00005293938,0.0002321331,0.000008930325],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691437,0.0164695,0.001126521,0.001415275,0.001512133,0.005089923,0.002027245,0.0002975883,0.002917981],"genre_scores_gemma":[0.9704874,0.008328025,0.00259271,0.002894507,0.001044865,0.007484269,0.001949759,0.00004706213,0.005171309],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00748347,"threshold_uncertainty_score":0.02503473,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1090696516901444,"score_gpt":0.3401949859973124,"score_spread":0.231125334307168,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}